Details About Generic Salt ::  Repaglin

Main Medicine Class:: Antidiabetic,meglitinide   

(HIGH-droe-moRE-phone HIGH-droe-KLOR-ide)

Prandin

Class: Antidiabetic/meglitinide

 

Drugs Class ::

 Action Decreases blood glucose by stimulating insulin release from the pancreas.

Indications for Drugs ::

 Indications Adjunct to diet and exercise to lower blood glucose in patients with non-insulin dependent diabetes mellitus (type II) whose hyperglycemia cannot be controlled by diet and exercise alone. Can be used with metformin when hyperglycemia cannot be controlled by exercise, diet and either repaglinide or metformin alone.

Drug Dose ::

 Route/Dosage

No fixed dosage regimen; periodically monitor blood glucose to determine minimum effective dose.

Patients not previously treated or whose HbA1_c is < 8%

ADULTS: PO Initial dose 0.5 mg with each meal.

Patients previously treated or whose HbA1_c is > 8%

ADULTS: PO Initial dose 1–2 mg with each meal.

Contraindication ::

 Contraindications Insulin-dependent (type I) diabetes; diabetic ketoacidosis with or without coma; hypersensitivity to repaglinide or its ingredients.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Insulin is recommended to maintain blood glucose levels during pregnancy. Lactation: Undetermined. Children: Safety and efficacy not established. Elderly and debilitated patients: Elderly and debilitated patients are particularly susceptible to the hypoglycemic action of repaglinide. Hypoglycemia may be difficult to recognize in the elderly. Administer with meals to lessen risk of hypoglycemia. Renal function impairment: Use caution when titrating repaglinide. Hepatic function impairment: Use with caution. Allow longer intervals between dosage adjustments.

PATIENT CARE CONSIDERATIONS

Drug Side Effects ::

 Adverse Reactions

GI: Nausea; vomiting; diarrhea; constipation; dyspepsia. META: Hypoglycemia; hyperglycemia. RESP: Upper respiratory infection; sinusitis; rhinitis; bronchitis. OTHER: Arthralgia; back pain; chest pain; headache; paresthesia; urinary tract infection; tooth disorder.

Drug Mode of Action ::  

 Action Decreases blood glucose by stimulating insulin release from the pancreas.

Drug Interactions ::

 Interactions

Erythromycin, ketoconazole, miconazole: May inhibit repaglinide metabolism. Barbiturates, carbamazepine, rifampin, troglitazone: May increase repaglinide metabolism. Protein bound drugs (eg, NSAIDs, salicylates, sulfonamides, probenecid, MAO inhibitors, beta-adrenergic blocking agents): May potentiate hypoglycemic effect of repaglinide.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies.
• Note hepatic or renal impairment and the nature of the patient’s diabetes (type I vs type II).
• Be aware that hypoglycemia may be difficult to recognize in the elderly.
• Check blood sugars frequently and observe for symptoms of hypoglycemia or hyperglycemia and report to physician.

OVERDOSAGE: SIGNS & SYMPTOMS   Hypoglycemia, seizure, neurologic impairment, coma.

Drug Storage/Management ::

 Administration/Storage

• Administer before meals. Can be taken immediately before or up to 30 mins before each meal.
• Hold dose if meal is missed.
• Add dose if meal is added.
• Dosage increases should occur no more frequently than weekly.
• Usual dose is 0.5–4 mg with each meal. Maximum daily dose is 16 mg/day.
• Store in a tightly capped container at room temperature; protect from moisture.

Drug Notes ::

 Patient/Family Education

• Review diabetic dietary guidelines with patient.
• Instruct patient to take drug immediately before or up to 30 mins before each meal.
• Instruct patients who skip a meal to skip their dose for that meal. If patient adds a meal they should be instructed to add a dose for that meal.
• Inform patient that this drug is not a substitute for exercise and diet control and that patient should follow prescribed regimens.
• Remind patient that follow-up visits will be required and to keep all appointments.
• Instruct patient to inform all healthcare providers involved in his/her care that he/she is taking this drug and to carry medical identification (eg, Medic-Alert bracelet).
• Instruct patient to notify physician if symptoms of hypoglycemia occur (fatigue, excessive hunger, profuse sweating, rapid heart rate, numbness of extremities) or if blood glucose is below 60 mg/dl.
• Instruct patient to notify physician if symptoms of hyperglycemia occur (excessive thirst or urination) or if blood glucose is consistently above 200 mg/dl.
• Instruct patient to report these symptoms to physician: nausea, vomiting, diarrhea or other physical complaints.
• Advise patient not to take any medication (including otc) or alcohol without consulting physician.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.